Ligands for CXC chemokine receptor 3 (CXCR3), which act downstream of IFN-γ and regulate Th1 pathways [17], have been evaluated for their applicability in the diagnosis of TB [18,19]. This evidence concerns the gene CXCR3 and tuberculosis.